Blue Owl Capital Holdings LP
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 11, 2026. SEC CIK 1858703.
- Reported value$664.5m
- Positions76
Holdings: 76 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Space Exploration Techn CorpSPCX | CLASS A COM STK | 84615Q103 | 239 | 36.0% | 1,398,815 | New+1,398,815 | |
| Aktis Oncology IncAKTS | COM | 01021M104 | 99.0 | 14.9% | 3,070,219 | Reduced−91,129 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 28.0 | 4.2% | 1,539,764 | Reduced−370,000 | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 27.9 | 4.2% | 9,163,157 | Added+2,043,150 | |
| Nuveen Churchill Direct LendNCDL | COM SHS | 67090S108 | 26.6 | 4.0% | 2,143,626 | Unchanged | |
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 26.2 | 3.9% | 729,929 | Reduced−276,000 | |
| Capital One Finl CorpCOF | COM | 14040H105 | 24.0 | 3.6% | 119,757 | New+119,757 | |
| Blue Owl Capital CorporationOBDC | COM | 69121K104 | 22.2 | 3.3% | 2,045,070 | Unchanged | |
| Deep Fission IncFISN | COM | 243927100 | 14.7 | 2.2% | 1,333,333 | New+1,333,333 | |
| Dell Technologies IncDELL | CL C | 24703L202 | 14.2 | 2.1% | 32,961 | Added+19,062 | |
| Holley IncHLLY | COM | 43538H103 | 11.2 | 1.7% | 4,376,888 | Added+140,000 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 10.9 | 1.6% | 762,594 | Reduced−150,000 | |
| Sagimet Biosciences IncSGMT | COM SER A | 786700104 | 9.7 | 1.5% | 1,260,544 | Added+926,667 | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 9.1 | 1.4% | 608,600 | Added+63,600 | |
| Artiva Biotherapeutics IncARTV | COM | 04317A107 | 8.5 | 1.3% | 874,542 | New+874,542 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 7.9 | 1.2% | 3,624,076 | Added+682,551 | |
| Conduent IncCNDT | COM | 206787103 | 7.4 | 1.1% | 5,036,595 | Unchanged | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 6.8 | 1.0% | 61,455 | Unchanged | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 6.4 | 1.0% | 450,000 | New+450,000 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 6.1 | 0.9% | 182,638 | Reduced−120,000 | |
| Palvella Therapeutics Inc NePVLA | COM | 697947109 | 5.5 | 0.8% | 36,259 | Added+5,000 | |
| Imagenebio IncIMA | COM | 45175G207 | 5.4 | 0.8% | 917,692 | Reduced−41,645 | |
| Compass Pathways plc | CALL | 20451W901 | 5.2 | 0.8% | 1,670,500 | Call | New+1,670,500 |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 4.8 | 0.7% | 260,000 | New+260,000 | |
| Immix Biopharma IncIMMX | COM | 45258H106 | 4.5 | 0.7% | 437,552 | Reduced−110,000 | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 4.3 | 0.7% | 400,000 | Added+250,000 | |
| Lenz Therapeutics IncLENZ | COM | 52635N103 | 4.3 | 0.6% | 756,722 | Added+250,000 | |
| Aquestive Therapeutics IncAQST | COM | 03843E104 | 3.9 | 0.6% | 942,932 | Reduced−405,000 | |
| Starwood Ppty TR IncSTWD | COM | 85571B105 | 3.2 | 0.5% | 196,355 | Added+37,810 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 2.4 | 0.4% | 180,000 | Added+80,000 | |
| Eledon Pharmaceuticals IncELDN | COM | 28617K101 | 2.2 | 0.3% | 566,509 | Reduced−853,403 | |
| Cabaletta Bio IncCABA | COM | 12674W109 | 2.2 | 0.3% | 714,710 | New+714,710 | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 1.8 | 0.3% | 89,878 | New+89,878 | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 1.6 | 0.2% | 2,934,015 | Reduced−2,155,000 | |
| WW International IncWW | COM | 98262P200 | 1.3 | 0.2% | 84,399 | Reduced−11,235 | |
| Marker Therapeutics IncMRKR | COM NEW | 57055L206 | 0.8 | 0.1% | 554,250 | Unchanged | |
| Erasca Inc | CALL | 29479A908 | 0.8 | 0.1% | 100,000 | Call | New+100,000 |
| ADC Therapeutics SA | SHS | H0036K147 | 0.8 | 0.1% | 733,568 | Unchanged | |
| Cybin Inc | COM NEW | 23256X407 | 0.4 | <0.1% | 59,911 | New+59,911 | |
| Fold Holdings IncFLD | COM CL A | 29103K100 | 0.4 | <0.1% | 856,632 | Unchanged | |
| Niocorp Devs LtdNB | *W EXP 03/17/202 | 654484153 | 0.4 | <0.1% | 268,280 | Reduced−51,820 | |
| Eledon Pharmaceuticals Inc | CALL | 28617K901 | 0.3 | <0.1% | 200,000 | Call | New+200,000 |
| Rezolve Ai plc | *W EXP 08/15/202 | G75398118 | 0.2 | <0.1% | 235,121 | Unchanged | |
| Brand Engagement Network IncBNAI | *W EXP 03/14/202 | 104932116 | 0.2 | <0.1% | 1,453,808 | Reduced−213,000 | |
| Piper Sandler CompaniesPIPR | COM NEW | 724078209 | 0.2 | <0.1% | 2,428 | Unchanged | |
| Engene Therapeutics IncENGN | *W EXP 10/31/202 | 29286X119 | 0.1 | <0.1% | 511,177 | New+511,177 | |
| Larimar Therapeutics Inc | CALL | 517125900 | 0.1 | <0.1% | 728,600 | Call | New+728,600 |
| Celcuity IncCELC | COM | 15102K100 | 0.1 | <0.1% | 1,249 | New+1,249 | |
| Compass Therapeutics Inc | CALL | 20454B904 | 0.1 | <0.1% | 303,800 | Call | New+303,800 |
| Stablecoinx IncUSDE | *W EXP 06/25/203 | 85238K118 | 0.1 | <0.1% | 250,000 | New+250,000 | |
| Energy Transfer L PET | COM UT LTD PTN | 29273V100 | 0.1 | <0.1% | 5,326 | Unchanged | |
| Caris Life Sciences IncCAI | COM | 142152107 | 0.1 | <0.1% | 4,711 | Unchanged | |
| Vodafone Group plcVOD | SPONSORED ADR | 92857W308 | 0.1 | <0.1% | 5,371 | New+5,371 | |
| Dave IncDAVE | *W EXP 01/05/202 | 23834J110 | 0.1 | <0.1% | 28,750 | Unchanged | |
| Murano Global Invt plc | SHS | G63369105 | 0.1 | <0.1% | 261,875 | New+261,875 | |
| Alpha Modus Holdings IncAMOD | *W EXP 12/13/202 | 020952115 | 0.1 | <0.1% | 1,854,665 | Unchanged | |
| Roadzen Inc | *W EXP 11/30/202 | G7606H116 | 0.0 | <0.1% | 225,000 | Unchanged | |
| Alpha Modus Holdings IncAMOD | CL A NEW | 020952206 | 0.0 | <0.1% | 9,853 | New+9,853 | |
| Aeon Biopharma IncAEON | CL A NEW | 00791X209 | 0.0 | <0.1% | 42,353 | Unchanged | |
| Southland Holdings Inc | *W EXP 02/14/202 | 84445C118 | 0.0 | <0.1% | 860,302 | Unchanged | |
| Blue Gold Ltd | *W EXP 04/01/203 | G1331C112 | 0.0 | <0.1% | 175,000 | Unchanged | |
| SHF Holdings Inc | CL A NEW | 824430300 | 0.0 | <0.1% | 75,897 | Unchanged | |
| Blacksky Technology Inc | *W EXP 09/09/202 | 09263B116 | 0.0 | <0.1% | 350,000 | Unchanged | |
| Tevogen Bio Holdings IncTVGN | *W EXP 02/14/202 | 88165K119 | 0.0 | <0.1% | 200,000 | Unchanged | |
| ZEO Energy CorpZEO | *W EXP 03/13/202 | 98944F117 | 0.0 | <0.1% | 250,000 | New+250,000 | |
| Livewire Group Inc | *W EXP 09/26/202 | 53838J113 | 0.0 | <0.1% | 400,000 | New+400,000 | |
| Nvni Group Limited | *W EXP 11/01/202 | G50716110 | 0.0 | <0.1% | 200,000 | New+200,000 | |
| Katapult Holdings IncKPLT | COM NEW | 485859201 | 0.0 | <0.1% | 5,421 | Unchanged | |
| CID Holdco IncDAIC | *W EXP 12/31/202 | 171756117 | 0.0 | <0.1% | 444,515 | Unchanged | |
| Baird Med Invt Holdings Ltd | *W EXP 10/01/202 | G0705H111 | 0.0 | <0.1% | 100,000 | Unchanged | |
| Pagaya Technologies Ltd | *W EXP 99/99/999 | M7S64L107 | 0.0 | <0.1% | 48,661 | Unchanged | |
| Stardust PWR IncSDST | *W EXP 06/21/202 | 854936119 | 0.0 | <0.1% | 16,666 | Unchanged | |
| Liminatus Pharma Inc.LIMN | *W EXP 04/30/203 | 53271X116 | 0.0 | <0.1% | 50,000 | Unchanged | |
| Waldencast plc | *W EXP 07/27/202 | G9503X111 | 0.0 | <0.1% | 33,333 | Unchanged | |
| XBP Global Holdings IncXBP | *W EXP 11/30/202 | 98400V119 | 0.0 | <0.1% | 24,778 | Unchanged | |
| Aspire Biopharma Holdings IncASBP | *W EXP 02/14/203 | 738920115 | 0.0 | <0.1% | 50,000 | Unchanged |
Sold out: 22 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Alpha Modus Holdings Inc | CL A | 020952107 | 0.0 | 0.0% | 0 | Sold out−394,078 | |
| Bitcoin Depot Inc | *W EXP 06/30/202 | 09174P113 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Cardinal Health IncCAH | COM | 14149Y108 | 0.0 | 0.0% | 0 | Sold out−1,718 | |
| CID Holdco Inc | COM | 171756109 | 0.0 | 0.0% | 0 | Sold out−557,361 | |
| Civeo Corp CdaCVEO | COM NEW | 17878Y207 | 0.0 | 0.0% | 0 | Sold out−180,475 | |
| Compass Pathways plc | CALL | 20451W901 | 0.0 | 0.0% | 0 | Sold out−1,804,504 | |
| Compass Therapeutics Inc | CALL | 20454B904 | 0.0 | 0.0% | 0 | Sold out−400,000 | |
| Engene Holdings Inc | *W EXP 10/31/202 | 29286M113 | 0.0 | 0.0% | 0 | Sold out−511,177 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−4,416,353 | |
| Enterprise Prods Partners LEPD | COM | 293792107 | 0.0 | 0.0% | 0 | Sold out−31,290 | |
| Gohealth Inc | CL A NEW | 38046W204 | 0.0 | 0.0% | 0 | Sold out−40,770 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−215,000 | |
| Katapult Holdings Inc | *W EXP 06/09/202 | 485859110 | 0.0 | 0.0% | 0 | Sold out−400,000 | |
| Larimar Therapeutics Inc | CALL | 517125900 | 0.0 | 0.0% | 0 | Sold out−975,700 | |
| Mineralys Therapeutics Inc | CALL | 603170901 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Olema Pharmaceuticals Inc | CALL | 68062P906 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 0.0 | 0.0% | 0 | Sold out−1,904,666 | |
| Pliant Therapeutics IncPLRX | COM | 729139105 | 0.0 | 0.0% | 0 | Sold out−2,969,199 | |
| Structure Therapeutics Inc | CALL | 86366E906 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Syntec Optics Holdings IncOPTX | *W EXP 99/99/999 | 87169M113 | 0.0 | 0.0% | 0 | Sold out−803,132 | |
| Viking Therapeutics Inc | CALL | 92686J906 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Vodafone Group plc | SPONSORED ADR | 00857W308 | 0.0 | 0.0% | 0 | Sold out−5,371 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-345031 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.